Application Information

This drug has been submitted to the FDA under the reference 208673/001.

Names and composition

"SOLIQUA 100/33" is the commercial name of a drug composed of INSULIN GLARGINE and LIXISENATIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
208673/001 SOLIQUA 100/33 INSULIN GLARGINE; LIXISENATIDE SOLUTION/SUBCUTANEOUS 300 UNITS per 3ML and 99MCG per 3ML (100 UNITS per ML and 33MCG per ML)

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
208673/001 SOLIQUA 100/33 INSULIN GLARGINE; LIXISENATIDE SOLUTION/SUBCUTANEOUS 300 UNITS per 3ML and 99MCG per 3ML (100 UNITS per ML and 33MCG per ML)

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved